The SPA17-AXL axis drives melanoma aggressiveness and SPA17-targeting vaccination exhibits antitumor efficacy - Quiz - MDSpire

The Role of the SPA17-AXL Pathway in Melanoma Progression and the Antitumor Potential of SPA17-Targeted Vaccination

By
Lan Zhang
Mengshu You
Bin Yan
Jian Zhang
Yi Yao
Qingyan Zhang
Zuozhong Xie
Shixiang Wang
Qian Gao
September 9, 2026

Frontiers In Immunology

Share

Original Source(s)

Frontiers In Immunology

The SPA17-AXL axis drives melanoma aggressiveness and SPA17-targeting vaccination exhibits antitumor efficacy

by Lan Zhang, Mengshu You, Bin Yan, Jian Zhang, Yi Yao, Qingyan Zhang, Zuozhong Xie, Shixiang Wang, Qian Gao
September 9, 2026

Related Content

Dermatology And Therapy

The Circadian Skin: Chronobiology as a New Frontier in Dermatological Therapy

by Diala Haykal
September 7, 2026

Frontiers In Medicine

Editorial: Tumor microenvironment and personalized therapy of gastrointestinal cancer Ⅱ

by Xinxin Wang, Jianming James Tang, Shuang Yang, Shuo Li
September 8, 2026

Frontiers In Medicine

Case Report: Possible spatially-distinct de novo invasive cervical carcinoma in the setting of isolated persistent HPV16 after ALA-PDT-mediated histological clearance of CIN3

by Huihui Cai, Yanci Che, Yutong Liu, Jing Wang, Tingting Ma, Rui Yao
September 8, 2026